TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04405297

Intervention type: DEVICE
Intervention: Adipose-derived regenerative cells
Description: Adipose-derived regenerative cells will be obtained from a small-volume lipoaspirate procedure. The lipoaspirate will then be enzymatically digested to produce a stromal vascular fraction (SVF) that will be injected into the targeted joint.

Intervention type: DEVICE
Intervention: Adipose-derived regenerative cells
Description: Adipose-derived regenerative cells will be obtained from a small-volume lipoaspirate procedure. The lipoaspirate will then be enzymatically digested to produce a stromal vascular fraction (SVF) that will be injected into the targeted joint.

Intervention type: DEVICE
Intervention: Adipose-derived regenerative cells
Description: Adipose-derived regenerative cells will be obtained from a small-volume lipoaspirate procedure. The lipoaspirate will then be enzymatically digested to produce a stromal vascular fraction (SVF) that will be injected into the targeted joint.

Intervention type: DEVICE
Intervention: Adipose-derived regenerative cells
Description: Adipose-derived regenerative cells will be obtained from a small-volume lipoaspirate procedure. The lipoaspirate will then be enzymatically digested to produce a stromal vascular fraction (SVF) that will be injected into the targeted joint.

Intervention type: DEVICE
Intervention: Adipose-derived regenerative cells
Description: Adipose-derived regenerative cells will be obtained from a small-volume lipoaspirate procedure. The lipoaspirate will then be enzymatically digested to produce a stromal vascular fraction (SVF) that will be injected into the targeted joint.
Study: NCT06582342

Intervention type: PROCEDURE
Intervention: Three dimensional imaging technology (3D-PANC MSP model)
Description: The processing of the CT images obtained in each center for the creation of the 3D model will be performed centrally by the team of radiologists and computer scientists of the company Cella Medical Solutions. This team will be blinded to the reports of the CT scans.For each patient 4 NCCN check-lists will be filled in without knowing the result of the surgery or the AP study: 2 based on the conventional CT and two based on the 3D-MSP study.

Intervention type: PROCEDURE
Intervention: Computerized tomography group (conventional CT)
Description: A multiphase CT (venous phase and pancreatographic phase) with 1mm thick slices and series of images in coronal, axial and sagittal reconstructions will be performed. This CT model will be performed at disease diagnosis and after completion of neoadjuvant chemotherapy treatment. Both CT scans will be independently reported by a radiologist from the hospital of origin. The preoperative CT scan will also be evaluated a posteriori by a radiologist from the sponsoring center with expertise in PAC. Both reports (the one from the radiologist of the center and the one from the radiologist of the sponsoring center) will be used to fill out the imaging study variables sheet based on the latest version of the NCCN 2022 guidelines. The radiologists will not know the outcome of the surgery or the anatomic pathology study at the time of the completion of the report.
Study: NCT05107271

Intervention type: DIAGNOSTIC_TEST
Intervention: COVID-19 serosurvey
Description: COVID-19 related antibody testing to assess immunogenicity of COVID-19 vaccines or post natural infection acquired immunity

Intervention type: DIAGNOSTIC_TEST
Intervention: COVID-19 serosurvey
Description: COVID-19 related antibody testing to assess immunogenicity of COVID-19 vaccines or post natural infection acquired immunity
Study: NCT05783232

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Control Form 1 Capsules
Description: Participants will use their Placebo Control Form 1 Capsules as directed for a period of 4 weeks.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Health Active Study Product 1.1 Capsules
Description: Participants will use their Radicle Health Active Study Product 1.1 Capsules as directed for a period of 4 weeks.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Health Active Study Product 1.2 Capsules
Description: Participants will use their Radicle Health Active Study Product 1.2 Capsules as directed for a period of 4 weeks.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Health Active Study Product 1.3 Capsules
Description: Participants will use their Radicle Health Active Study Product 1.3 Capsules as directed for a period of 4 weeks.
Study: NCT04700137

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Caring Contacts Plus Introductory Phone Call (CC+)
Description: One introductory semi-structured caring phone conversation with a follow-up specialist to check-in, establish a personal connection, and provide resources at the 0-2 week time-point followed by 11 non-demanding, caring text or email messages sent over the course of 6 months.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Caring Contacts without an introductory phone call (CC)
Description: Eleven non-demanding, caring text or email messages sent over the course of 6 months. Participants will not know or have spoken to the follow-up specialist who sends the caring messages.
Study: NCT04587999

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: bladder stimulation
Description: The bladder stimulation technique requires the presence of 2 people:~* The child must be held by an adult (caregiver or parent) under the armpits, legs dangling.~* the first person (the investigator), performs the stimulation technique consisting of: rapid tapping (frequency of about 100 / min), over the pubic area, at the level of the bladder, alternated with external rotational movements of the pits lumbar, in the kidneys. Alternate these 2 maneuvers every 30 seconds.~* The second person starts the stopwatch at the start of the stimulation, and is about to collect the urine, 2nd jet in a sterile pot~* The maneuver ends as soon as urine is obtained, and will be stopped after 5 minutes in case of failure.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Quick wee
Description: The Quick wee technique requires the presence of only one person:~Stimulation of the suprapubic area by circular movements, with a cold and wet compress held by sterile forceps.~Collection of urine in a sterile container.
Study: NCT05478252

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Semaglutide J
Description: Participants will initially receive 0.25 mg subcutaneous injections of semaglutide J OW and the dose will be then escalated once in 4 weeks for 8 weeks until the target maintenance dose of 1.0 mg is reached which will be maintained for a period of 20 weeks: 0.25 mg (week 1 to week 4), 0.5 mg (week 5 to week 8), 1.0 mg (week 9 to week 28).

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Semaglutide B
Description: Participants will initially receive 0.25 mg subcutaneous injections of semaglutide B OW and the dose will be then escalated once in 4 weeks for 8 weeks until the target maintenance dose of 1.0 mg is reached which will be maintained for a period of 20 weeks: 0.25 mg (week 1 to week 4), 0.5 mg (week 5 to week 8), 1.0 mg (week 9 to week 28).
Study: NCT04884373

Intervention type: DIAGNOSTIC_TEST
Intervention: Gastric ultrasound
Description: An ultrasound exam will be performed before induction of anaesthesia. GUS results from selected patients will be systematically acquired and assessed following an algorithm (Appendix Ia). The ultrasound results will be collected on a standardized form (Appendix IIa). The technique is performed in the supine and right lateral decubitus position (Appendix Ib) and only by anesthesiologists with sufficient experience with ultrasound and the technique. The patient will be asked to indicate his/her satiety on a predetermined ten-point scale.
Study: NCT04663230

Intervention type: DIAGNOSTIC_TEST
Intervention: cardiac magnetic resonance imaging
Description: right atrial late gadolinium enhancement in % and cm2
Study: NCT06363656

Intervention type: DEVICE
Intervention: Wears the smartwatch during the sleep time to capture sleep characteristics and answer questionaires
Description: * Synchronization of smartwatch with smartphone (internet connection) to send sleep characteristics captured by the application~* Weight~* Height~* Body measurements (circumferences)~* Questionnaires about overall health status~* Pittsburgh Sleep Quality Index questionnaire~* Insomnia Severity Index~* Sleep Hygiene Index~* Epworth Sleepiness Scale~* NoSAS score (Neck, Obesity, Snoring, Age, Sex)
Study: NCT04663230

Intervention type: DIAGNOSTIC_TEST
Intervention: cardiac magnetic resonance imaging
Description: right atrial late gadolinium enhancement in % and cm2

Intervention type: DIAGNOSTIC_TEST
Intervention: cardiac magnetic resonance imaging
Description: right atrial late gadolinium enhancement in % and cm2
Study: NCT06089512

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: paravertebral block group
Description: Paravertebral block was applied to the patients after induction of general anesthesia; Intraoperative opioid requirement and postoperative pain scores and analgesic requirement were evaluated.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Mid point transverse process block group
Description: Mid point transverse process block was applied to the patients after induction of general anesthesia; Intraoperative opioid requirement and postoperative pain scores and analgesic requirement were evaluated.

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Control group
Description: Only general anesthesia was applied to the patients.
Study: NCT06364904

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab, Cisplatin, Gemcitabine and Trilaciclib
Description: Chemoimmunotherapy:~1. Tislelizumab: 200mg, 1x time at d1 each cycle~2. Gemcitabine: 1000mg/ m2, in d1, d8 each cycle~3. Cisplatin: 70 mg/m2, in d2 each cycle~4. Trilaciclib: 240mg/m2, d1, d2, d8 each cycle~Tislelizumab maintenance therapy: after chemoimmunotherapy, 200mg, q3W.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tislelizumab, Cisplatin, Gemcitabine
Description: Chemoimmunotherapy:~1. Tislelizumab: 200mg, 1x time at d1 each cycle~2. Gemcitabine: 1000mg/ m2, in d1, d8 each cycle~3. Cisplatin: 70 mg/m2, in d2 each cycle~Tislelizumab maintenance therapy: after chemoimmunotherapy, 200mg, q3W.
Study: NCT04572750

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: EMPOWER-ED
Description: An electronic app that runs on a variety of platforms and provides education and tools designed to promote self-driven reduction of benzodiazepines.
Study: NCT05215301

Intervention type: DIAGNOSTIC_TEST
Intervention: Multidimensional Voice Program
Description: MDVP (Multidimensional Voice Program) is a computerized acoustic analysis used to analyze sound quality using various parameters. Multidimensional Voice Program (MDVP) 4500 produced by Kay Elemetric Corp was used for voice evaluation.~Research subjects were asked to make a vowel sound /a/ using the same tone and intensity as the subject's daily speech. The researcher will give an example before letting the research subject tries. Voice recording was done using a microphone connected to a computer with the MDVP program. Voice recording was done in a quiet room for at least 3 seconds with a microphone distance of 10 cm from the mouth of the research subject. The recorded sound will be directly analyzed with the MDVP program. Sound recording was done 3 - 5 times, and the best sound acoustic analysis results were used for the study.

Intervention type: DIAGNOSTIC_TEST
Intervention: Multidimensional Voice Program
Description: MDVP (Multidimensional Voice Program) is a computerized acoustic analysis used to analyze sound quality using various parameters. Multidimensional Voice Program (MDVP) 4500 produced by Kay Elemetric Corp was used for voice evaluation.~Research subjects were asked to make a vowel sound /a/ using the same tone and intensity as the subject's daily speech. The researcher will give an example before letting the research subject tries. Voice recording was done using a microphone connected to a computer with the MDVP program. Voice recording was done in a quiet room for at least 3 seconds with a microphone distance of 10 cm from the mouth of the research subject. The recorded sound will be directly analyzed with the MDVP program. Sound recording was done 3 - 5 times, and the best sound acoustic analysis results were used for the study.
Study: NCT06154161

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Whey protein supplement
Description: A monthly supply of 35 g of whey protein isolate will be provided to participants in individual sachet packets with instructions of preparation. Every month, participants will come to the center to provide the standard monthly blood sample. At this time, the PI will have participants complete the quality-of-life instrument, ask if there have been any changes in their dietary habits, and collect weights for up to 6-months. Additionally, participants will indicate if they had consumed the protein daily and/or bring back their empty/full satchel packets. As this is a feasibility trial, it is necessary to determine the compliancy of consuming protein daily and the amount. Furthermore, understanding how protein markers may be affected by consumption of the protein daily vs less frequently throughout the week is important to establish improved recommendations for consumption of protein supplements.
Study: NCT04766554

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cerebral oximetry monitor (The INVOS® Cerebral/Somatic Oximeter) and protocol-based interventions
Description: In the intervention group, an alarm threshold below 15% of the baseline rSO2 value will be established. Based on the predetermined algorithm the rSO2 will be maintained at or above 85% of the baseline measurements. If the rSO2 reaches levels below 15% of the baseline values or below 50% in absolute value for over 30 seconds, protocol-based interventions will be performed to restore rSO2 to baseline levels.
Study: NCT05239273

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Complex Decongestive Therapy
Description: Phase 1 of CDT will be applied. This application consists of manual lymph drainage, skin care, compression bandage and exercises.

Intervention type: OTHER
Group type: OTHER
Intervention: Control
Description: No intervention
Study: NCT06101199

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acute Intermittent Hypercapnic Hypoxia
Description: 15 x \[1 min 9% O2, 4% CO2, and balance N2, followed by 1.5 min normoxia\];
Study: NCT04838509

Intervention type: OTHER
Intervention: no intervention
Description: retrospective descriptive without intervention
Study: NCT05093842

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sedentary Behavior Reduction
Description: Participants receive bimonthly behavioral health coaching, a sit-stand desk attachment or table, and an activity prompter if they do not already have one (e.g., fitbit, as needed).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Information on Physical Activity Recommendations during Pregnancy
Description: Participants in the study will receive educational materials provided one time by email about the currently recommended physical activity during pregnancy.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Information on Physical Activity Recommendations during Pregnancy
Description: Participants in the study will receive educational materials provided one time by email about the currently recommended physical activity during pregnancy.
Study: NCT05139550

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Smartphone Rehabilitation Application
Description: Upper Limb Exercise Protocol:~Passive Exercises~ROMs for shoulder, ROMs for elbow, ROMs for wrist,fingers and thumb~Active/Assisted Exercises~bilateral shoulder flexion with both hands interlocked, Elbow pronation and supination, Wrist flexion and extension with the help of unaffected hand, Forearm to box, Extend elbow (side), Hand to box (front)~Functional Activities~Lift can, Lift pencil, Lift paper clip, Stack checkers,Flip cards, Fold towel, drinking water from a glass, lifting a glass of water to a level of 90° shoulder flexion with an extended elbow, moving 5 crystals from the table to a box, wiping the table with a towel with the elbow extended, grasping and releasing a 6 cm in diameter tennis ball, combing their hair, Eating with affected hand, opening and closing jars
Study: NCT04720027

Intervention type: DIAGNOSTIC_TEST
Intervention: Duplex imaging
Description: Completion of AVVQ and EQ5D questionnairs

Intervention type: DIAGNOSTIC_TEST
Intervention: Duplex imaging
Description: Completion of AVVQ and EQ5D questionnairs

Intervention type: DIAGNOSTIC_TEST
Intervention: Duplex imaging
Description: Completion of AVVQ and EQ5D questionnairs
Study: NCT05414422

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PCN-101
Description: Concentrate for solution for infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PCN-101
Description: Concentrate for solution for infusion

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Concentrate for solution for infusion
Study: NCT05845554

Intervention type: DIAGNOSTIC_TEST
Intervention: The extracted DNA from bile samples will be analyzed by BileCAD to determine the level of CIN.
Description: The extracted gDNA from bile sample will be analyzed by BileCAD to determine the level of CINs.

Intervention type: DIAGNOSTIC_TEST
Intervention: The extracted DNA from bile samples will be analyzed by BileCAD to determine the level of CIN.
Description: The extracted gDNA from bile sample will be analyzed by BileCAD to determine the level of CINs.
Study: NCT06073470

Intervention type: DRUG
Intervention: methylphenidate
Description: The patients with ADHD will receive 12-week treatment with methylphenidate.
Study: NCT06275802

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nutrition Education
Description: Nutrition interventions consisting of 8 modules (powerpoint supported classroom lesson, video demonstration, role-play, healthy plate model game, poster preparation, bookmarks, refrigerator magnets, etc. preparation of reminder messages, competitions such as slogan-painting contest, activities such as sports and nutrition festival).

Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: nutritional status, eating habits
Description: At the beginning of the study (June 2022), an introductory form (sociodemographic characteristics, body image (Stunkart scale), dietary habits, knowledge about weight status) was applied to all students. Adolescent Nutrition Literacy Scale (ANLS), Instrument of Nutrition Literacy, Mediterranean Diet Quality Index (KID-MED), Eating Attitudes Test 26 (EAT-26), International Physical Activity Questionnaire Short Form (IPAQ) were applied, anthropometric measurements and three-day food consumption records were taken
Study: NCT06101199

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Acute Intermittent Hypercapnic Hypoxia
Description: 15 x \[1 min 9% O2, 4% CO2, and balance N2, followed by 1.5 min normoxia\];
Study: NCT06275802

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: nutritional status, eating habits
Description: At the beginning of the study (June 2022), an introductory form (sociodemographic characteristics, body image (Stunkart scale), dietary habits, knowledge about weight status) was applied to all students. Adolescent Nutrition Literacy Scale (ANLS), Instrument of Nutrition Literacy, Mediterranean Diet Quality Index (KID-MED), Eating Attitudes Test 26 (EAT-26), International Physical Activity Questionnaire Short Form (IPAQ) were applied, anthropometric measurements and three-day food consumption records were taken
Study: NCT06101199

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Transcutaneous spinal cord stimulation
Description: Open-loop, continuous, high-frequency electrical stimulation at 150 Hz with a tolerable current amplitude of \~25-35 mA and a pulse width of 400 µsec, using a biphasic symmetric waveform. Paired with Respiratory Resistance Training and Hand Grip Strength Training.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Transcutaneous spinal cord stimulation
Description: Open-loop, continuous, high-frequency electrical stimulation at 150 Hz with a tolerable current amplitude of \~25-35 mA and a pulse width of 400 µsec, using a biphasic symmetric waveform. Paired with Respiratory Resistance Training and Hand Grip Strength Training.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: SHAM Acute Intermittent Hypercapnic Hypoxia
Description: Normoxia for the amount of time AIHH is delivered.
Study: NCT06171646

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: breathing exercise
Description: The patients in the intervention group will first be informed by the researcher about pursed lips and diaphragmatic breathing exercises through a face-to-face interview technique, and then the breathing exercises will be taught practically to each patient for approximately 30 minutes, and the first session will be held. Each session takes place once a day in the morning, lasts 10-15 minutes and is applied every day; Sessions other than the first session will consist of 10 pursed lip breathing exercises, relaxation (2 minutes) and 10 diaphragmatic breathing exercises; Three days a week, the researcher will be reminded via online video call once a day in the morning, and on the other days, the patients will be reminded by phone call that they will be asked to do themselves, and breathing exercises will be performed for a total of four weeks.